194668-71-8 Usage
Uses
Used in Medicinal Chemistry:
6-Bromo-2-mercaptothiazolo[4,5-b]pyridine is used as a pharmaceutical intermediate for its antimicrobial and antiviral properties. Its unique structure allows it to be a promising candidate in the development of new drugs targeting various infectious diseases.
Used in Organic Synthesis:
6-Bromo-2-mercaptothiazolo[4,5-b]pyridine is used as a building block in the synthesis of more complex organic molecules. Its versatile chemical properties make it a valuable component in creating a wide range of compounds for various applications.
Used in Pharmaceutical Development:
6-Bromo-2-mercaptothiazolo[4,5-b]pyridine is used as a key scaffold in the development of pharmaceuticals. Its unique structure and biological activities contribute to the design and synthesis of new drugs with potential therapeutic benefits.
Used in Agrochemicals:
6-Bromo-2-mercaptothiazolo[4,5-b]pyridine is used in the development of agrochemicals, particularly as a component in the creation of new pesticides or herbicides. Its antimicrobial properties can be harnessed to protect crops from various pathogens.
It is important to handle 6-Bromo-2-mercaptothiazolo[4,5-b]pyridine with care, as it may pose health and environmental hazards due to its chemical properties. Proper safety measures should be taken during its production, use, and disposal to minimize any potential risks.
Check Digit Verification of cas no
The CAS Registry Mumber 194668-71-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,9,4,6,6 and 8 respectively; the second part has 2 digits, 7 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 194668-71:
(8*1)+(7*9)+(6*4)+(5*6)+(4*6)+(3*8)+(2*7)+(1*1)=188
188 % 10 = 8
So 194668-71-8 is a valid CAS Registry Number.
194668-71-8Relevant academic research and scientific papers
FUSED PYRIDINES WHICH ACT AS INHIBITORS OF H-PGDS
-
Page/Page column 69; 70, (2019/07/19)
A compound of formula (I) wherein R1, R2, R3, R4 χ γ anc| A are as defined herein. The compounds of the present invention are inhibitors of hematopoietic prostaglandin D synthase (H-PGDS) and can be useful in th
NOVEL BICYCLIC HETEROCYCLIC COMPOUND
-
Paragraph 0751; 0752; 0753, (2018/09/27)
Provided are a novel compound having a superior inhibitory action on KAT-II, a production method thereof, use thereof, and a pharmaceutical composition containing the aforementioned compound and the like. A compound represented by the formula (I) or a pharmacologically acceptable salt thereof. wherein each symbol is as defined in the DESCRIPTION.
